Monoclonal Antibody Therapy in Treating Patients With Leukemia

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of radiolabeled monoclonal antibody plus pentetic acid calcium in patients with leukemia.

Timeline

Start

1996-10

Primary completion

—

Completion

2006-07

Drugs

Indications